Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04349644 · ClinicalTrials.gov registry record · NA

Enhancing Social Competence in Adults With Autism

A NA study of Autism Spectrum Disorder, sponsored by Vanderbilt University Medical Center.

Completed
Registry status
NA
Development phase
72
Enrollment target
1
Study location

NCT04349644 is a NA study of Autism Spectrum Disorder that has completed, run by Vanderbilt University Medical Center. The registered enrollment target is 72 participants, below the 135-participant average among 224 other Autism Spectrum Disorder trials with a reported enrollment target (47% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04349644, a NA study of Autism Spectrum Disorder, has completed, sponsored by Vanderbilt University Medical Center.

COMPLETED
Registry status
NA
Development phase
72 participants
Enrollment target
1
Study location

Study Summary

SENSE Theatre®, combines several well-documented, effective behavioral strategies, such as the inclusion of trained peer models, theatre play techniques involving predictable (i.e., scripted) and flexible (improvised) role-play, and repeated performance of newly learned skills resulting in greater automaticity of behavior. The intervention has the potential to enhance social cognition and behavior in adults with autism spectrum disorder.

Conditions Studied

Interventions

  • BEHAVIORAL SENSE Theatre

Study Locations (1)

Tennessee

  • Vanderbilt University Medical Center - Nashville

Trial Details

FieldValue
Enrollment Target 72 participants
Start Date 2020-10-21
Est. Completion 2025-03-30
Phase NA

What the Registry Record Tells You About NCT04349644

The ClinicalTrials.gov registry entry for NCT04349644 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 72 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 135-participant average among 224 other Autism Spectrum Disorder trials with a reported enrollment target (47% lower). The listed sponsor is Vanderbilt University Medical Center, which has 677 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Autism Spectrum Disorder appearing as the primary indexed condition, and to 1 intervention - of which SENSE Theatre is the first listed.

NCT04349644 reports 1 study location spanning 1 distinct geographic area - top geographies include Tennessee.

Frequently Asked Questions

What is clinical trial NCT04349644 about?

NCT04349644 is a clinical study titled "Enhancing Social Competence in Adults With Autism". SENSE Theatre®, combines several well-documented, effective behavioral strategies, such as the inclusion of trained peer models, theatre play techniques involving predictable (i.e., scripted) and flexible (improvised) role-play, and repeated performance of newly learned skills resulting in greater a...

What is the current status of trial NCT04349644?

This trial is currently completed. It is a NA study. The enrollment target is 72 participants. The study started on 2020-10-21. Estimated completion is 2025-03-30.

What conditions does trial NCT04349644 study?

This clinical trial studies the following conditions: Autism Spectrum Disorder.

What interventions are being tested in trial NCT04349644?

The interventions under investigation include: SENSE Theatre (BEHAVIORAL).

Who is sponsoring clinical trial NCT04349644?

This trial is sponsored by Vanderbilt University Medical Center, which has 677 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04349644 being conducted?

This trial has 1 study location across Tennessee. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Autism Spectrum Disorder

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.